Welcome to LookChem.com Sign In|Join Free

CAS

  • or

615-34-9

Post Buying Request

615-34-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

615-34-9 Usage

General Description

Methyl (2S)-2,3-dihydroxypropanoate, also known as L-methyl lactate, is a chemical compound with the molecular formula C4H8O4. It is a colorless liquid with a sweet odor, often used as a flavoring agent and fragrance ingredient. It is commonly produced through the esterification of lactic acid with methanol. L-methyl lactate is used in various industries including food and beverage, pharmaceuticals, and cosmetics, and is often utilized as a solvent or a component in skincare and personal care products. It is considered to be relatively safe for use in these applications, although it should be handled and stored with proper precautions due to its potential irritant properties.

Check Digit Verification of cas no

The CAS Registry Mumber 615-34-9 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 6,1 and 5 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 615-34:
(5*6)+(4*1)+(3*5)+(2*3)+(1*4)=59
59 % 10 = 9
So 615-34-9 is a valid CAS Registry Number.

615-34-9Relevant articles and documents

Base-free conversion of glycerol to methyl lactate using a multifunctional catalytic system consisting of Au-Pd nanoparticles on carbon nanotubes and Sn-MCM-41-XS

Tang, Zhenchen,Boer, Dina G.,Syariati, Ali,Enache, Mihaela,Rudolf, Petra,Heeres, Hero J.,Pescarmona, Paolo P.

, p. 4115 - 4126 (2019/08/12)

Multifunctional catalytic systems consisting of physical mixtures of (i) bimetallic Au-Pd nanoparticles (average size of 3-5 nm) supported on functionalised carbon nanotubes (CNTs) and (ii) Sn-MCM-41 nanoparticles (50-120 nm), were synthesised and investigated for the base-free, selective conversion of glycerol to methyl lactate in a batch reactor. The catalysts were characterised by means of transmission electron microscopy, N2-physisorption, energy-dispersive X-ray spectroscopy, X-ray photoelectron spectroscopy and by Boehm titration. The catalyst based on bimetallic AuPd/CNTs showed much higher activity than the monometallic Au or Pd counterparts, thus indicating synergetic effects. Functionalisation of the CNTs by oxidative treatments had a positive effect on catalyst performance, which was correlated to the observed increase in surface acidity and hydrophilicity. The highest yield of methyl lactate achieved in this work was 85% at 96% glycerol conversion (140 °C, 10 h at 30 bar air), which is the highest yield ever reported in the literature so far. Insights in the reaction pathway were obtained by monitoring the conversion-time profiles for intermediates and their possible role as inhibitors. Batch recycling experiments demonstrated the excellent reusability of the catalyst.

Dihydroxylation of Olefins with Potassium Permanganate Catalyzed by Imidazolium Salt

Khan, Imran,Luo, Zhi-Bin,Valeru, Anil,Xu, Yin,Liu, Bin,Sangepu, Bhavanarushi,Xie, Ji-Min

, p. 1815 - 1819 (2018/02/19)

The development of an efficient and cost-effective cis -dihydroxylation reaction of acrylate derivatives was achieved. The reaction proceeded in acetone with an imidazolium salt as catalyst to furnish the dihydroxylation of olefins at 0-5 °C using KMnO 4 as the oxidant. This efficient and non-aqueous protocol was highly suitable for the large-scale preparation of cis -dihydroxylated compounds from the corresponding acrylate derivatives in high yields without overoxidation.

NOVEL PYRAZOLO PYRIMIDINE DERIVATIVES AND THEIR USE AS MALT1 INHIBITORS

-

Page/Page column 42; 43, (2015/12/31)

The present invention describes new pyrazolo-pyrimidine derivatives of formula (I) or a pharmaceutically acceptable salt thereof; (I) wherein, R1 is halogen, cyano, or C1-C3alkyl optionally substituted by halogen; R2 is C1-C6alkyl optionally substituted one or more times by C1-C6alkyl, C2-C6alkenyl, hydroxyl, N,N-di-C1-C6alkyl amino, N-mono-C1-C6alkyl amino, O-Rg, Rg, phenyl, or by C1-C6alkoxy wherein said alkoxy again may optionally be substituted by C1-C6alkoxy, N,N-di-C1-C6alkyl amino, Rg or phenyl; C3-C6cycloalkyl optionally substituted by C1-C6alkyl, N,N-di-C1-C6alkyl amino or C1-C6alkoxy-C1-C6alkyl, and/or two of said optional substituents together with the atoms to which they are bound may form an annulated or spirocyclic 4 - 6 membered saturated heterocyclic ring comprising 1 - 2 O atoms; phenyl optionally substituted by C1-C6alkoxy; a 5 - 6 membered heteroaryl ring having 1 to 3 heteroatoms selected from N and O said ring being optionally substituted by C1-C6alkyl which may be optionally substituted by amino or hydroxy; Rg; or N,N-di-C1-C6alkyl amino carbonyl; and R is phenyl independently substituted two or more times by Ra, 2-pyridyl independently substituted one or more times by Rb, 3-pyridyl independently substituted one or more times by Rc, or 4-pyridyl independently substituted one or more times by Rd; which are generally interacting with MALT1 proteolytic and/or autoproteolytic activity, and in particular which may inhibit said activity. The present invention further describes the synthesis of said new pyrazolo-pyrimidine derivatives, their use as a medicament, especially by interacting with MALT1 proteolytic and/or autoproteolytic activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 615-34-9